Maravai LifeSciences Holdings, Inc. - Class A common stock (NQ:MRVI)

6.790 -0.280 (-3.96%)

Delayed Quote Updated: 4:00 PM EDT, Oct 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Maravai LifeSciences Holdings, Inc. - Class A common stock

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 4, 2026

October 14, 2026

From Maravai LifeSciences, Inc.

Via Business Wire

TriLink BioTechnologies® Secures Additional China Patent for CleanCap® Technology, Adding Broad Composition-of-Matter Protection to Reinforce Its Global IP

September 29, 2026

From TriLink BioTechnologies, LLC

Via Business Wire

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

August 19, 2026

Via Chartmill

Maravai (MRVI) Q2 2026 Earnings Call Transcript ↗

August 13, 2026

Revenue grew 8.5% to $51.4 million as mRNA discovery demand surged.

Via The Motley Fool

Topics Earnings

Maravai Lifesciences (NASDAQ:MRVI) Shares Slide Despite Q2 Beat as Full-Year Revenue Outlook Weighs ↗

August 06, 2026

Via Chartmill

Maravai LifeSciences Q2 Earnings Call Highlights ↗

August 07, 2026

Maravai LifeSciences (NASDAQ:MRVI) reported second-quarter 2026 revenue growth and a sharp improvement in adjusted profitability, while maintaining its full-year revenue outlook and raising its...

Via MarketBeat

Topics Earnings

Maravai LifeSciences Reports Second Quarter 2026 Financial Results

August 06, 2026

From Maravai LifeSciences Holdings, Inc.

Via Business Wire

Maravai LifeSciences To Host Earnings Conference Call on Thursday, August 6, 2026

July 22, 2026

From Maravai LifeSciences, Inc.

Via Business Wire

TriLink BioTechnologies® Further Strengthens Global IP Position with Newly Issued Patent in China for CleanCap® Capping Technology

July 20, 2026

From TriLink BioTechnologies, LLC

Via Business Wire

Maravai LifeSciences (NASDAQ:MRVI) Surges After Crushing Q1 Estimates and Raising Full-Year Guidance ↗

May 07, 2026

Via Chartmill

Maravai Lifesciences (NASDAQ:MRVI) Returns to Positive Adjusted EBITDA and Issues 2026 Guidance ↗

February 25, 2026

Via Chartmill

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

TriLink Opens GMP Enzyme Manufacturing Facility, Enabling Integrated IVT Supply from R&D to Commercial Scale

June 16, 2026

From Maravai LifeSciences

Via Business Wire

Maravai LifeSciences Announces Refinancing of Credit Agreement, Extending Maturity to 2032

June 03, 2026

From Maravai LifeSciences Holdings, Inc.

Via Business Wire

Maravai LifeSciences To Attend The Jefferies Global Healthcare Conference

May 18, 2026

From Maravai LifeSciences, Inc.

Via Business Wire

Maravai (MRVI) Q1 2026 Earnings Transcript ↗

May 09, 2026

Maravai (MRVI) Q1 2026 Earnings Transcript

Via The Motley Fool

Maravai LifeSciences Q1 Earnings Call Highlights ↗

May 08, 2026

Maravai LifeSciences (NASDAQ:MRVI) reported first-quarter fiscal 2026 results that management said marked a “strong start to 2026,” driven by growth at its TriLink segment, steady contribution from...

Via MarketBeat

Topics Earnings

Get insights into the top gainers and losers of Thursday's after-hours session. ↗

May 07, 2026

Via Chartmill

Maravai LifeSciences Reports First Quarter 2026 Financial Results

May 07, 2026

From Maravai LifeSciences Holdings, Inc.

Via Business Wire

Maravai LifeSciences To Host Earnings Conference Call on Thursday, May 7, 2026

April 20, 2026

From Maravai LifeSciences, Inc.

Via Business Wire

Top movers in Wednesday's after hours session ↗

February 25, 2026

Via Chartmill

Maravai Lifesciences Reports Fourth Quarter and Full Year 2025 Financial Results

February 25, 2026

From Maravai LifeSciences Holdings, Inc.

Via Business Wire

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, February 25, 2026

February 09, 2026

From Maravai LifeSciences, Inc.

Via Business Wire

Teleflex Stock Slides 39% in a Year, but This $8.5 Million Buy Signals a Contrarian Bet ↗

February 06, 2026

This medical device firm supplies hospitals worldwide with single-use products for critical care, surgery, and interventional procedures.

Via The Motley Fool

Topics Regulatory Compliance

What to Know About a New $9 Million Bet on an Energy Distributor Stock ↗

February 06, 2026

This energy sector distributor delivers maintenance, repair, and supply chain solutions to industrial clients across a global network.

Via The Motley Fool

Topics Economy Regulatory Compliance

This Biopharma Stock Has Surged Nearly 100% and One Fund Just Locked in Gains With a $10 Million Exit ↗

February 06, 2026

Arcutis Biotherapeutics develops topical therapies for chronic skin conditions, with a portfolio targeting psoriasis and atopic dermatitis.

Via The Motley Fool

Maravai LifeSciences Announces November 2025 Investor Conference Schedule

November 10, 2025

From Maravai LifeSciences, Inc.

Via Business Wire

Maravai LifeSciences (MRVI) Stock Plummets After Q3 2025 Revenue Miss and Weak Guidance ↗

November 06, 2025

Maravai LifeSciences (MRVI) stock fell after Q3 2025 revenue missed estimates. The company reported a net loss and provided full-year guidance below analyst expectations.

Via Chartmill

Maravai LifeSciences Reports Third Quarter 2025 Financial Results

November 06, 2025

From Maravai LifeSciences Holdings, Inc.

Via Business Wire

MARAVAI INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Continues Investigation on Behalf of Maravai Long-Term Stockholders

October 29, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.